Jpmorgan Chase & CO Oncology Institute, Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Oncology Institute, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 170 shares of TOI stock, worth $52. This represents 0.0% of its overall portfolio holdings.
Number of Shares
170
Previous 8,766
98.06%
Holding current value
$52
Previous $13,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding TOI
# of Institutions
41Shares Held
14.2MCall Options Held
83.9KPut Options Held
0-
Deerfield Management Company, L.P. (Series C) New York, NY3.36MShares$1.04 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.78MShares$552,8700.0% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.75MShares$542,5000.37% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.73MShares$534,9240.0% of portfolio
-
Tiff Advisory Services Inc1.42MShares$439,7920.22% of portfolio
About Oncology Institute, Inc.
- Ticker TOI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 73,495,504
- Market Cap $22.8M
- Description
- The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical tr...